Philip Insel

Doktorand
Fler filtreringsmöjligheter
  1. 2020
  2. Comparing progression biomarkers in clinical trials of early Alzheimer’s disease

    Nicholas C. Cullen, Henrik Zetterberg, Philip S. Insel, Bob Olsson, Ulf Andreasson, Kaj Blennow, Oskar Hansson & Niklas Mattsson-Carlgren, 2020 aug 11, I : Annals of Clinical and Translational Neurology.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. The A4 study: β-amyloid and cognition in 4432 cognitively unimpaired adults

    Philip S. Insel, Michael C. Donohue, Reisa Sperling, Oskar Hansson & Niklas Mattsson-Carlgren, 2020 apr 21, I : Annals of Clinical and Translational Neurology.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  4. Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer's disease

    Niklas Mattsson-Carlgren, Emelie Andersson, Shorena Janelidze, Rik Ossenkoppele, Philip Insel, Olof Strandberg, Henrik Zetterberg, Howard J. Rosen, Gil Rabinovici, Xiyun Chai, Kaj Blennow, Jeffrey L. Dage, Erik Stomrud, Ruben Smith, Sebastian Palmqvist & Oskar Hansson, 2020, I : Science Advances. 6, 16, eaaz2387.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. Depression Severity, but Not Cognitive Impairment or Frailty, is Associated with Disability in Late-Life Depression

    Ruth T. Morin, Philip Insel, David Bickford, Craig Nelson & R. Scott Mackin, 2020, I : Clinical Gerontologist. 43, 4, s. 411-419 9 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  6. Somatic and anxiety symptoms of depression are associated with disability in late life depression

    Ruth T. Morin, Craig Nelson, David Bickford, Philip S. Insel & R. Scott Mackin, 2020, I : Aging and Mental Health. 24, 8, s. 1225-1228 4 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  7. 2019
  8. Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease

    Sebastian Palmqvist, Philip S. Insel, Erik Stomrud, Shorena Janelidze, Henrik Zetterberg, Britta Brix, Udo Eichenlaub, Jeffrey L. Dage, Xiyun Chai, Kaj Blennow, Niklas Mattsson & Oskar Hansson, 2019 dec 1, I : EMBO Molecular Medicine. 11, 12, e11170.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  9. Determining clinically meaningful decline in preclinical Alzheimer disease

    Philip S. Insel, Michael Weiner, R. Scott Mackin, Elizabeth Mormino, Yen Ying Lim, Erik Stomrud, Sebastian Palmqvist, Colin L. Masters, Paul T. Maruff, Oskar Hansson & Niklas Mattsson, 2019 jul 23, I : Neurology. 93, 4, s. e322-e333

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  10. Associations between tau, Aβ, and cortical thickness with cognition in Alzheimer disease

    Rik Ossenkoppele, Ruben Smith, Tomas Ohlsson, Olof Strandberg, Niklas Mattsson, Philip S. Insel, Sebastian Palmqvist & Oskar Hansson, 2019 feb 9, I : Neurology. 92, 6, s. e601-e612

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  11. Serum Neurofilament Light Chain for Prognosis of Outcome after Cardiac Arrest

    Marion Moseby-Knappe, Niklas Mattsson, Niklas Nielsen, Henrik Zetterberg, Kaj Blennow, Josef Dankiewicz, Irina Dragancea, Hans Friberg, Gisela Lilja, Philip S. Insel, Christian Rylander, Erik Westhall, Jesper Kjaergaard, Matt P. Wise, Christian Hassager, Michael A. Kuiper, Pascal Stammet, Michael C.Jaeger Wanscher, Jørn Wetterslev, David Erlinge & 3 andra, Janneke Horn, Tommaso Pellis & Tobias Cronberg, 2019 jan 1, I : JAMA Neurology. 76, 1, s. 64

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  12. Accurate risk estimation of β-amyloid positivity to identify prodromal Alzheimer's disease: Cross-validation study of practical algorithms

    Sebastian Palmqvist, Philip S. Insel, Henrik Zetterberg, Kaj Blennow, Britta Brix, Erik Stomrud, Niklas Mattsson, Oskar Hansson, The Alzheimer's Disease Neuroimaging Initiative The Alzheimer's Disease Neuroimaging Initiative & The Swedish BioFINDER study The Swedish BioFINDER study, 2019, I : Alzheimer's and Dementia. 15, 2, s. 194-204

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  13. Latent Classes of Cognitive Functioning among Depressed Older Adults Without Dementia

    Ruth T. Morin, Philip Insel, Craig Nelson, Meryl Butters, David Bickford, Susan Landau, Andrew Saykin, Michael Weiner & R. Scott Mackin, 2019, I : Journal of the International Neuropsychological Society. 25, 8, s. 811-820

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  14. 2018
  15. Effects of APOE ε4 on neuroimaging, cerebrospinal fluid biomarkers, and cognition in prodromal Alzheimer's disease

    Niklas Mattsson, Oscar Eriksson, Olof Lindberg, Michael Schöll, Björn Lampinen, Markus Nilsson, Philip S. Insel, Ronald Lautner, Olof Strandberg, Danielle van Westen, Henrik Zetterberg, Kaj Blennow, Sebastian Palmqvist, Erik Stomrud & Oskar Hansson, 2018 nov 1, I : Neurobiology of Aging. 71, s. 81-90 10 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  16. Amyloid pathology in the progression to mild cognitive impairment

    Philip S. Insel, Oskar Hansson, R. Scott Mackin, Michael Weiner, Niklas Mattsson & Alzheimer's Disease Neuroimaging Initiative Alzheimer's Disease Neuroimaging Initiative, 2018 apr, I : Neurobiology of Aging. 64, s. 76-84 9 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  17. Comparing 18 F-AV-1451 with CSF t-tau and p-tau for diagnosis of Alzheimer disease

    Niklas Mattsson, Ruben Smith, Olof Strandberg, Sebastian Palmqvist, Michael Schöll, Philip S. Insel, Douglas Hägerström, Tomas Ohlsson, Henrik Zetterberg, Kaj Blennow, Jonas Jögi & Oskar Hansson, 2018 jan 30, I : Neurology. 90, 5, s. e388-e395

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  18. Chronic depressive symptomatology and CSF amyloid beta and tau levels in mild cognitive impairment

    Mitzi M. Gonzales, Philip S. Insel, Craig Nelson, Duygu Tosun, Michael Schöll, Niklas Mattsson, Simona Sacuiu, David Bickford, Michael W. Weiner, R. Scott Mackin & The Alzheimer's Disease Neuroimaging Initiative The Alzheimer's Disease Neuroimaging Initiative, 2018, I : International Journal of Geriatric Psychiatry. 33, 10, s. 1305-1311 7 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  19. 2017
  20. Serum tau and neurological outcome in cardiac arrest

    Niklas Mattsson, Henrik Zetterberg, Niklas Nielsen, Kaj Blennow, Josef Dankiewicz, Hans Friberg, Gisela Lilja, Philip S. Insel, Christian Rylander, Pascal Stammet, Anders Aneman, Christian Hassager, Jesper Kjaergaard, Michael Kuiper, Tommaso Pellis, Jørn Wetterslev, Matthew Wise & Tobias Cronberg, 2017 nov 2, I : Annals of Neurology. 82, 5, s. 665-675 11 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  21. Preclinical effects of APOE ϵ4 on cerebrospinal fluid Aβ42 concentrations

    Ronald Lautner, Philip S. Insel, Tobias Skillbäck, Bob Olsson, Mikael Landén, Giovanni B Frisoni, Sanna-Kaisa Herukka, Harald Hampel, Anders Wallin, Lennart Minthon, Oskar Hansson, Kaj Blennow, Niklas Mattsson & Henrik Zetterberg, 2017 okt 23, I : Alzheimer's Research and Therapy. 9, 1, 87.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  22. Time to amyloid positivity and preclinical changes in brain metabolism, atrophy, and cognition: Evidence for emerging amyloid pathology in alzheimer's disease

    Philip S. Insel, Rik Ossenkoppele, Devon Gessert, William J Jagust, Susan M Landau, Oskar Hansson, Michael W Weiner, Niklas Mattsson & Alzheimer's Disease Neuroimaging Initiative Alzheimer's Disease Neuroimaging Initiative, 2017 maj 17, I : Frontiers in Neuroscience. 11, MAY, 281.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  23. Cross-validation of optimized composites for preclinical Alzheimer's disease

    Michael C. Donohue, Chung Kai Sun, Rema Raman, Philip S. Insel & Paul S. Aisen, 2017 jan 1, I : Alzheimer's and Dementia: Translational Research and Clinical Interventions. 3, 1, s. 123-129 7 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  24. Cortical Atrophy is Associated with Accelerated Cognitive Decline in Mild Cognitive Impairment with Subsyndromal Depression

    Alzheimer's Disease Neuroimaging Initiative Alzheimer's Disease Neuroimaging Initiative, 2017, I : American Journal of Geriatric Psychiatry. 25, 9, s. 980-991

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  25. 18F-AV-1451 and CSF T-tau and P-tau as biomarkers in Alzheimer's disease

    Niklas Mattsson, Michael Schöll, Olof Strandberg, Ruben Smith, Sebastian Palmqvist, Philip S. Insel, Douglas Hägerström, Tomas Ohlsson, Henrik Zetterberg, Jonas Jögi, Kaj Blennow & Oskar Hansson, 2017, I : EMBO Molecular Medicine. 9, s. 1212-1223

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  26. 2016
  27. Cognitive and functional changes associated with Aβ pathology and the progression to mild cognitive impairment

    Philip S. Insel, Michael C. Donohue, R. Scott Mackin, Paul S. Aisen, Oskar Hansson, Michael W. Weiner & Niklas Mattsson, 2016 dec, I : Neurobiology of Aging. 48, s. 172-181 10 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  28. Plasma tau in Alzheimer disease

    Niklas Mattsson, Henrik Zetterberg, Shorena Janelidze, Philip S. Insel, Ulf Andreasson, Erik Stomrud, Sebastian Palmqvist, David Baker, Cristina A. Tan Hehir, Andreas Jeromin, David Hanlon, Linan Song, Leslie M. Shaw, John Q. Trojanowski, Michael W. Weiner, Oskar Hansson & Kaj Blennow, 2016 okt 25, I : Neurology. 87, 17, s. 1827-1835 9 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  29. Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease

    Niklas Mattsson, Philip S. Insel, Sebastian Palmqvist, Erik Portelius, Henrik Zetterberg, Michael Weiner, Kaj Blennow & Oskar Hansson, 2016 okt 1, I : EMBO Molecular Medicine. 8, 10, s. 1184-1196 13 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  30. Accelerating rates of cognitive decline and imaging markers associated with β-amyloid pathology

    Philip S. Insel, Niklas Mattsson, R. Scott Mackin, Michael Schöll, Rachel L. Nosheny, Duygu Tosun, Michael C. Donohue, Paul S. Aisen, William J. Jagust & Michael W. Weiner, 2016 maj 17, I : Neurology. 86, 20, s. 1887-1896 10 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  31. Chronic Depressive Symptomatology in Mild Cognitive Impairment Is Associated with Frontal Atrophy Rate which Hastens Conversion to Alzheimer Dementia

    Simona Sacuiu, Philip S Insel, Susanne Mueller, Duygu Tosun, Niklas Mattsson, Clifford R Jack, Charles DeCarli, Ronald C Petersen, Paul S. Aisen, Michael W Weiner, R Scott Mackin & Alzheimer's Disease Neuroimaging Initiative Alzheimer's Disease Neuroimaging Initiative, 2016 feb, I : American Journal of Geriatric Psychiatry. 24, 2, s. 126-35 10 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  32. Assessing risk for preclinical β-amyloid pathology with APOE, cognitive, and demographic information

    Philip S. Insel, Sebastian Palmqvist, R. Scott Mackin, Rachel L. Nosheny, Oskar Hansson, Michael W. Weiner & Niklas Mattsson, 2016, I : Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring. 4, s. 76-84 9 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift